Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Paschalis Paranos

Title(s)Postdoctoral Scholar - Research Associate
SchoolUSC School of Pharmacy
Address1985 Zonal Ave.
Health Sciences Campus
Los Angeles CA 90033
ORCID ORCID Icon0000-0003-1934-8691 Additional info
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Therapeutic application of a jumbo bacteriophage against metallo-ß-lactamase producing Pseudomonas aeruginosa clinical isolates. J Biomed Sci. 2025 Aug 11; 32(1):74. Paranos P, Skliros D, Zrelovs N, Georgiou PC, Svanberga K, Kazaks A, Kostakis M, Thomaidis N, Flemetakis E, Meletiadis J. PMID: 40790594; PMCID: PMC12337514.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Designing an effective phage cocktail against Klebsiella pneumoniae covering metallo-ß-lactamases producing multi-drug resistant clinical isolates. Microb Pathog. 2025 Nov; 208:107926. Paranos P, Skliros D, Zrelovs N, Georgiou PC, Siopi M, Svanberga K, Kazaks A, Kostakis M, Thomaidis N, Flemetakis E, Meletiadis J. PMID: 40714272.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    3. Reversal of phenotypic resistance in multi-drug resistant carbapenemase-producing K. pneumoniae clinical isolates due to in vitro synergistic interactions between bacteriophages and antibiotics at clinically achievable concentrations. J Antimicrob Chemother. 2025 May 31. Paranos P, Siopi M, Papanikolaou E, Vourli S, Kolia P, Pournaras S, Meletiadis J. PMID: 40448542.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. In Vitro Interactions Between Bacteriophages and Antibacterial Agents of Various Classes Against Multidrug-Resistant Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Clinical Isolates. Pharmaceuticals (Basel). 2025 Feb 27; 18(3). Paranos P, Vourli S, Pournaras S, Meletiadis J. PMID: 40143121; PMCID: PMC11945160.
      View in: PubMed   Mentions: 2  
    5. Detection of Phage's Lytic Activity Against Carbapenemase-Producing Klebsiella pneumoniae Isolates Using a High-Throughput Microbroth Growth Inhibition Assay. Infect Dis Ther. 2025 Jan; 14(1):217-228. Paranos P, Pournaras S, Meletiadis J. PMID: 39709574; PMCID: PMC11782791.
      View in: PubMed   Mentions: 3  
    6. A single-layer spot assay for easy, fast, and high-throughput quantitation of phages against multidrug-resistant Gram-negative pathogens. J Clin Microbiol. 2024 Aug 14; 62(8):e0074324. Paranos P, Pournaras S, Meletiadis J. PMID: 39072625; PMCID: PMC11323465.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    7. Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Rev. 2024 Sep 12; 37(3):e0004424. Siopi M, Skliros D, Paranos P, Koumasi N, Flemetakis E, Pournaras S, Meletiadis J. PMID: 39072666; PMCID: PMC11391690.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    8. Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023. Euro Surveill. 2024 Jul; 29(29). Siopi M, Georgiou PC, Paranos P, Beredaki MI, Tarpatzi A, Kalogeropoulou E, Damianidou S, Vasilakopoulou A, Karakosta P, Pournaras S, Meletiadis J. PMID: 39027938; PMCID: PMC11258949.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Severe mold fungal infections in critically ill patients with COVID-19. Future Microbiol. 2024 Jun 12; 19(9):825-840. Koulenti D, Paramythiotou E, Almyroudi MP, Karvouniaris M, Markou N, Paranos P, Routsi C, Meletiadis J, Blot S. PMID: 38700287; PMCID: PMC11290760.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    10. Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance? J Fungi (Basel). 2024 Mar 14; 10(3). Paranos P, Espinel-Ingroff A, Meletiadis J. PMID: 38535222; PMCID: PMC10971485.
      View in: PubMed   Mentions: 2  
    11. Severe Candida infections in critically ill patients with COVID-19. J Intensive Med. 2023 Oct 31; 3(4):291-297. Koulenti D, Karvouniaris M, Paramythiotou E, Koliakos N, Markou N, Paranos P, Meletiadis J, Blot S. PMID: 38028641; PMCID: PMC10658040.
      View in: PubMed   Mentions: 11  
    12. Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling. Pharmaceuticals (Basel). 2022 Nov 30; 15(12). Paranos P, Vourli S, Pournaras S, Meletiadis J. PMID: 36558952; PMCID: PMC9781251.
      View in: PubMed   Mentions: 10  
    13. Pharmacodynamics of colistin resistance in carbapenemase-producing Klebsiella pneumoniae: the double-edged sword of heteroresistance and adaptive resistance. J Med Microbiol. 2022 Oct; 71(10). Meletiadis J, Paranos P, Tsala M, Pournaras S, Vourli S. PMID: 36201344.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    14. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates. Int J Antimicrob Agents. 2021 Nov; 58(5):106440. Meletiadis J, Paranos P, Georgiou PC, Vourli S, Antonopoulou S, Michelaki A, Vagiakou E, Pournaras S. PMID: 34551356.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    Paschalis's Networks
    Concepts (61)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.